Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 1 institution in 1 country.
Marta GilBioISI-Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisbon, Portugal.
Ana Caulino-RochaBioISI-Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisbon, Portugal.
Marta BentoBioISI-Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisbon, Portugal.
Nádia C RodriguesUnidade de Neurociências, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisbon, Portugal.
Armando Silva-CruzUnidade de Neurociências, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisbon, Portugal.
Joaquim A RibeiroUnidade de Neurociências, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisbon, Portugal.
Diana Cunha-ReisBioISI-Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisbon, Portugal.ORCID 0000-0002-0900-9306
University of Lisbon · PT
Funding
Erasmus+ Mobility Fellowship for marta GilFundação para a Ciência e Tecnologia FCT/POCTI (PTDC/SAUPUB/28311/2017) EPIRaft grantFundação para a Ciência e Tecnologia Norma Transitória - DL57/2016/CP1479/CT0044 to DCR (DOI: 10.54499/DL57/2016/CP1479/CT0044)Fundação para a Ciência e Tecnologia SFRH/BPD/81358/2011 to DCRFundação para a Ciência e Tecnologia UIDB/04046/2020 (DOI: 10.54499/UIDB/04046/2020)Fundação para a Ciência e Tecnologia UIDP/04046/2020 (DOI: 10.54499/UIDP/04046/2020)
6 · The paper itself
Abstract
Long-term potentiation (LTP) induced by theta-burst stimulation (TBS) undergoes postweaning developmental changes partially linked to GABAergic circuit maturation. Endogenous vasoactive intestinal peptide (VIP) acting on its VPAC
Indexed as
Long-Term PotentiationTranscranial Magnetic StimulationAnimalsHippocampusInterneuronsNeuronal PlasticityRatsgephyrinhippocampusPSD-95theta-burst LTPVGATVGlut1VIPVPAC1 receptor
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Postweaning Development Influences Endogenous VPAC · full record | OpenQuestion